|
|
|
| Webinar: Hype vs Hands On: The Truth About End-to-End Manufacturing Automation | Invetech dives into the real-world tools reshaping cell and gene therapy manufacturing. Forget the lab—today’s bottlenecks are infrastructure. Discover how end-to-end automation, modular platforms, and AI-driven analytics can slash timelines, cut variability, and hardwire compliance. Learn how to spot automation opportunities early and future-proof your process for fast-changing therapies and regulatory demands. Don’t scale the science—industrialize it. Click here to learn more. |
|
|
|
|
By Kelly Cycon, BioSci Consulting | Preventive measures wane as a sense of security resumes. Follow these tips to protect business continuity in the next global health crisis. | |
|
|
|
|
| Advanced Technology Platform For Stem Cell-Derived Exosomes | Poster | By Elie Zakhem, Jae Jung, Cameron Garland, and Michael Boychyn, RoosterBio and Lauren Torres, Mario Sinani, Carl Breuning, Jeremy Neidert, and Rachel Legmann, Repligen | Demand for EVs is rising due to their therapeutic promise. Explore two scalable platforms that address production challenges to support EVs' expanding clinical and commercial applications. |
|
|
|
|
|
|
|
|
| Webinar: Next-Gen Disease Models & Cell Therapeutics: Innovations in AI, Omics and Collaboration | Join Thermo Fisher Scientific for a webinar exploring how innovations in 3D disease models, multi-omics integration, AI/machine learning, and global collaboration are transforming healthcare. Experts will address regulatory and ethical considerations and strategies for bridging research to clinical application. Learn how these advancements are improving patient outcomes and accelerating the development of personalized therapies. Click here to learn more. |
|
|
|
|
|
|
|
|
|
| Webinar: Accelerating Cell & Gene Therapy Scale-Up With An Advanced Manufacturing Platform | Discover how Oribiotech and ElevateBio are revolutionizing cell and gene therapy manufacturing with IRO —a next-gen platform delivering superior biological performance, real-time monitoring, and automated scalability. This webinar reveals how closed, efficient systems reduce costs and complexity while boosting consistency and quality from early development to commercialization. Learn how to scale smarter and faster in the evolving CGT landscape. Register here. |
|
|
|
| Advancing the Future of Cell & Gene Therapy | This November 11 - 12, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
| Connect With Cell & Gene: |
|
|
|
